329 related articles for article (PubMed ID: 17999872)
21. Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases.
Rashikh A; Ahmad SJ; Pillai KK; Najmi AK
J Pharm Pharmacol; 2012 Apr; 64(4):470-81. PubMed ID: 22420653
[TBL] [Abstract][Full Text] [Related]
22. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
[TBL] [Abstract][Full Text] [Related]
23. Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension.
Allikmets K
Vasc Health Risk Manag; 2007; 3(6):809-15. PubMed ID: 18200801
[TBL] [Abstract][Full Text] [Related]
24. Aliskiren: a new drug for an old problem.
Barrios V; Escobar C
Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):1-10. PubMed ID: 20210772
[TBL] [Abstract][Full Text] [Related]
25. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
[TBL] [Abstract][Full Text] [Related]
26. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
27. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
Dalla Vestra M; Simioni N; Masiero A
Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
[TBL] [Abstract][Full Text] [Related]
28. Aliskiren: the first renin inhibitor for clinical treatment.
Jensen C; Herold P; Brunner HR
Nat Rev Drug Discov; 2008 May; 7(5):399-410. PubMed ID: 18340340
[TBL] [Abstract][Full Text] [Related]
29. Aliskiren.
Anderson DL
Drugs Today (Barc); 2007 Dec; 43(12):849-55. PubMed ID: 18174970
[TBL] [Abstract][Full Text] [Related]
30. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Pimenta E; Oparil S
Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229
[TBL] [Abstract][Full Text] [Related]
31. Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
Sepehrdad R; Frishman WH; Stier CT; Sica DA
Cardiol Rev; 2007; 15(5):242-56. PubMed ID: 17700383
[TBL] [Abstract][Full Text] [Related]
32. Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunities.
Volpe M; Pontremoli R; Borghi C
High Blood Press Cardiovasc Prev; 2011 Sep; 18(3):93-105. PubMed ID: 21950781
[TBL] [Abstract][Full Text] [Related]
33. Renin inhibition for hypertension: selecting the right role for a new class of drug.
Bergset J; Storozynsky E; Bisognano JD
Am J Ther; 2010; 17(2):182-7. PubMed ID: 19433972
[TBL] [Abstract][Full Text] [Related]
34. Clinical role of direct renin inhibition in hypertension.
Taylor AA; Pool JL
Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
[TBL] [Abstract][Full Text] [Related]
35. Direct renin inhibition: an update.
Pinto R; Gradman AH
Curr Hypertens Rep; 2009 Dec; 11(6):456-62. PubMed ID: 19895758
[TBL] [Abstract][Full Text] [Related]
36. New class of agents for treatment of hypertension: focus on direct renin inhibition.
Fogari R; Zoppi A
Vasc Health Risk Manag; 2010 Oct; 6():869-82. PubMed ID: 20957132
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.
Buczko W; Hermanowicz JM
Pharmacol Rep; 2008; 60(5):623-31. PubMed ID: 19066408
[TBL] [Abstract][Full Text] [Related]
38. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Gerc V; Buksa M; Loza V; Kulic M
Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
[TBL] [Abstract][Full Text] [Related]
39. Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension.
Moutzouri E; Florentin M; Elisaf MS; Mikhailidis DP; Liberopoulos EN
Curr Vasc Pharmacol; 2010 May; 8(3):344-62. PubMed ID: 20180771
[TBL] [Abstract][Full Text] [Related]
40. [What is renin inhibition? Mechanism of action].
Timurkaynak T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():5-14. PubMed ID: 20019471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
